Zobrazeno 1 - 10
of 374
pro vyhledávání: '"Hedgehog pathway inhibitor"'
Publikováno v:
Case Reports in Dermatology, Vol 16, Iss 1, Pp 173-180 (2024)
Introduction: Basal cell carcinoma (BCC) is treated with local surgery or noninvasive treatment modalities. If a BCC remains untreated, it can develop into a locally advanced BCC or a metastatic BCC. Case Presentation: Here we report in detail the ma
Externí odkaz:
https://doaj.org/article/28e86aa25fd14e17971924d8dd0fbaf5
Publikováno v:
Cancer Treatment and Research Communications, Vol 39, Iss , Pp 100796- (2024)
The management of periocular basal cell carcinoma (BCC) is challenging due to its proximity to the eyeball. Vismodegib, a Hedgehog pathway inhibitor, has emerged as a therapeutic option for locally advanced and metastatic BCC. To critically appraise
Externí odkaz:
https://doaj.org/article/83389ffd7bd44836affccf52371e5525
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
JPRAS Open, Vol 34, Iss , Pp 168-172 (2022)
Summary: The management of advanced basal cell carcinoma (BCC) can be challenging and often involves a multi-disciplinary approach with dermatologists, plastic surgeons, and oncologists. Standard therapy for advanced BCCs has historically involved pr
Externí odkaz:
https://doaj.org/article/731893e395cd4ff59fba410411685393
Publikováno v:
Actas Dermo-Sifiliográficas, Vol 113, Iss 5, Pp 443-450 (2022)
Resumen: El carcinoma de células basales (CBC) es una de las neoplasias malignas más frecuentes, por lo que se ha convertido en una importante carga asistencial. Su incidencia se incrementa anualmente, especialmente en la población con mayor edad.
Externí odkaz:
https://doaj.org/article/4cd27de71381468bb66bbeea13cf589b
Autor:
Annika Belzer, BS, Jolanta Pach, BS, Ryland D. Mortlock, BS, James Clune, MD, Kelly Olino, MD, Mario Sznol, MD, Aarti Bhatia, MD, MPH, Barbara Burtness, MD, Sean Christensen, MD, PhD, Jonathan S. Leventhal, MD
Publikováno v:
JAAD International, Vol 11, Iss , Pp 174-175 (2023)
Externí odkaz:
https://doaj.org/article/688703ca2dd34aacafe1b31efb879652
Autor:
Ralf Gutzmer, Caroline Robert, Carmen Loquai, Dirk Schadendorf, Nicholas Squittieri, Ramon Arntz, Serena Martelli, Reinhard Dummer
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The BOLT study for sonidegib, a Hedgehog pathway inhibitor (HHI) approved for patients with locally advanced basal cell carcinoma (laBCC) not amenable to curative surgery or radiotherapy, used modified Response Evaluation Criteria
Externí odkaz:
https://doaj.org/article/9318906b3570461fb547c379286e05d0
Autor:
Liang Joo Leow, Vicki Howard
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/26bb5f9729004dee87026b2910303d34
Autor:
Florian Herms, Barouyr Baroudjian, Julie Delyon, Pauline Laly, Pauline Tetu, Celeste Lebbe, Nicole Basset-Seguin
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Sonidegib, a hedgehog pathway inhibitor, is indicated for treatment of locally advanced basal cell carcinoma, based on the results of the BOLT study. However, to date, no real-world study of sonidegib has been reported. An observational, retrospectiv
Externí odkaz:
https://doaj.org/article/23642922a497424ab038e598cbcf6543
Autor:
Babette J.A. Verkouteren, Kelly A.E. Sinx, Marie G.H.C. Reinders, Maureen J.B. Aarts, Klara Mosterd
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Some patients with basal cell carcinoma develop a large number of basal cell carcinomas during their lives. The most common underlying genetic disease that causes multiple basal cell carcinomas is basal cell naevus syndrome. Basal cell naevus syndrom
Externí odkaz:
https://doaj.org/article/84317966de2b4e69bd8d1a8e5b7629b7